Diastika Biotekindo Tbk PT
IDX:CHEK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Diastika Biotekindo Tbk PT
IDX:CHEK
|
ID |
|
DEV Information Technology Ltd
NSE:DEVIT
|
IN |
Intrinsic Value
The intrinsic value of Diastika Biotekindo Tbk PT (CHEK) under the Base Case is 50.27 IDR per share. Compared with the current market price of 119 IDR, the stock appears Overvalued by 58% .
The intrinsic value is calculated using the DCF method. The model assumes net margin rises from 7% last year to 9.3% by 2031, above last year's 7%. Revenue grows about 15% a year over the next five years.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Diastika Biotekindo Tbk PT Does
PT Diastika Biotekindo Tbk sells laboratory and diagnostic products used by hospitals, clinics, universities, research labs, and industrial customers in Indonesia. Its business is centered on supplying testing tools, reagents, and related lab equipment that help customers analyze samples, run diagnostics, and support quality control work.
- Headquarters
- Indonesia ID
- Employees
- 106
- IPO date
- Jul 10, 2025
Earnings Waterfall
Diastika Biotekindo Tbk PT
The intrinsic value for Diastika Biotekindo Tbk PT (CHEK) under the Base Case is 50.27 IDR.
Compared with the current market price of 119 IDR, the stock appears Overvalued by 58% .